Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Bierhaus A, Wolf J, Andrassy M et al. (2003) A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci U S A 100:1920–1925
Biesinger E, Heiden C, Greimel V, Lendle T, Hoing R, Albegger K (1998) Strategien in der ambulanten Behandlung des Tinnitus. HNO 46:157–169
Claussen E, Claussen CF, Patil NP (1998) On the effect of magnesium-aspartate in the neurootological therapy for vertigo and tinnitus. In: Claussen CF, Kitane MV, Schlitter N (eds) Vertigo, nausea, tinnitus and hypacusis in metabolic disorders. Experta Medica, Amsterdam, pp 529–532
DeBartolo HM Jr (1989) Zinc and diet for tinnitus. Am J Otol 10:256
Denk DM, Brix R, Felix D, Ehrenberger K (1992) Tinnitus therapy with transmitters. In: Aran JM, Dauman R (eds) Tinnitus 91. Kugler, Amsterdam, pp 119–121
Denk DM, Heinzl H, Franz P, Ehrenberger K (1997) Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol 117:825–830
Doerr TD, Dziadziola JK, Komjathy DA, Burgio DL, Quirk WS (1998) The effects of flunarizine and pentoxifylline on vestibular blood flow in the guinea pig. Eur Arch Otorhinolaryngol 255:385–390
Ehrenberger K, Denk D-M, Felix D (1995) Rezeptorpharmakologische Modelle für eine kausale Tinnitustherapie. Otorhinolaryngol Nova 5:148–152
Ehrenberger K, Felix D (1995) Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey. Acta Otolaryngol 115:236–240
Fowler EPJr (1953) Intravenous procaine in the treatment of Meniere’s disease. Ann Otol Rhinol Laryngol 62:1186–1200
Gananca MM, Caovilla HH, Gananca FF, Gananca CF, Munhoz MS, da Silva ML, Serafini F (2002) Clonazepam in the pharmacological treatment of vertigo and tinnitus. Int Tinnitus J 8:50–53
Ganzer U, Arnold W (1997) Ohrgeräusche, Leitlinien/Algorithmen der Dt. Ges. f. Hals-Nasen-Ohrenheilkunde, Kopf-und Hals-Chirurgie. HNO 45:670–672
Gunther T, Ising H, Joachims Z (1989) Biochemical mechanisms affecting susceptibility to noise-induced hearing loss. Am J Otol 10:36–41
Hultcrantz E, Nuttall AL (1987) Effect of hemodilution on cochlear blood flow measured by laser-Doppler flowmetry. Am J Otolaryngol 8:16–22
Joachims HZ, Segal J, Golz A, Netzer A, Goldenberg D (2003) Antioxidants in treatment of idiopathic sudden hearing loss. Otol Neurotol 24:572–575
Kaltenbach JA, Zacharek MA, Zhang J, Frederick S (2004) Activity in the dorsal cochlear nucleus of hamsters previously tested for tinnitus following intense tone exposure. Neurosci Lett 355:121–125
Kaltenbach JA, Zhang J, Afman CE (2000) Plasticity of spontaneous neural activity in the dorsal cochlear nucleus after intense sound exposure. Hear Res 147:282–292
Kawamoto K, Sha SH, Minoda R, Izumikawa M, Kuriyama H, Schacht J, Raphael Y (2004) Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9:173–181
Kronenberg J, Almagor M, Bendet E, Kushnir D (1992) Vasoactive therapy versus placebo in the treatment of sudden hearing loss: a double-blind clinical study. Laryngoscope 102:65–68
Lamm K (1995) Rationale Grundlagen einer Innenohrtherapie. Otorhinolaryngol Nova 5:153–160
Lamm K (1999) Ist eine durchblutungsfördernde Therapie bei cochleo-vestibulären Funktionsstörungn wirksam? HNO 47:155–156
Lamm K, Arnold W (1998) The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noise-damaged guinea pig inner ear. Hear Res 115:149–161
Lenarz T (1989) Medikamentöse Tinnitus-Therapie; Klinische und tierexperimentelle Untersuchung zur Pharmakologie der Hörbahn. Thieme, Stuttgart
Lewy BR (1937) Treatment of tinnitus aurium by the intravenous use of local anesthetic agents. Arch Otorhinolaryngol 25:178–183
Lopez Gonzalez MA, Muratori Leon ML, Moreno VJ (2003) [Sulpiride as initial treatment in tinnitus retraining therapy]. Acta Otorrinolaringol Esp 54:237–241
Michel O, Jahns T, Joost-Enneking M, Neugebauer P, Streppel M, Stennert E (2000) Das antiphlogistisch-rheologische Infusionsschema nach Stennert in der Behandlung von kochleo-vestibulären Störungen. HNO 48:182–188
Oestreicher E, Arnold W, Ehrenberger K, Felix D (1998) Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells. ORL J Otorhinolaryngol Relat Spec 60:18–21
Paaske PB, Pedersen CB, Kjems G, Sam IL (1991) Zinc in the management of tinnitus. Placebo-controlled trial. Ann Otol Rhinol Laryngol 100:647–649
Probst R, Tschopp K, Ludin E, Kellerhals B, Podvinec M, Pfaltz CR (1992) A randomized, double-blind, placebocontrolled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 112:435–443
Puel JL, Ruel J, Guitton M, Wang J, Pujol R (2002) The inner hair cell synaptic complex: physiology, pharmacology and new therapeutic strategies. Audiol Neurootol 7:49–54
Rarey KE, Curtis LM (1996) Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 115:38–41
Reyes SA, Salvi RJ, Burkard RF, Coad ML, Wack DS, Galantowicz PJ, Lockwood AH (2002) Brain imaging of the effects of lidocaine on tinnitus. Hear Res 171:43–50
Rudack C, Hillebrandt M, Wagenmann M, Hauser U (1997) Tinnitusbehandlung mit Lidocain? HNO 45:69–73
Schaaf H, Holtmann H (2002) Psychotherapie bei Tinnitus. Schattauer, Stuttgart New York, S 42
Scheibe F, Haupt H, Ising H (2000) Preventive effect of magnesium supplement on noise-induced hearing loss in the guinea pig. Eur Arch Otorhinolaryngol 257:10–16
Scherer EQ, Wangemann P (2002) ETA receptors in the gerbil spiral modiolar artery. Adv Otorhinolaryngol 59:58–65
Schwab B (2001) Infusionstherapie mit Procain bei akutem Tinnitus. HNO 49:852–853
Sha SH, Taylor R, Forge A, Schacht J (2001) Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals. Hear Res 155:1–8
Shemen L (1998) Fluoxetine for treatment of tinnitus. Otolaryngol Head Neck Surg 118:421
Simpson JJ, Davies WE (2000) A review of evidence in support of a role for 5-HT in the perception of tinnitus. Hear Res 145:1–7
Stöver T (2003) Genexpression, Genregulation und Gentransfer im Innenohr. Laryngorhinootologie 82:40–41
Szczepaniak WS, Moller AR (1996) Effects of (-)-baclofen, clonazepam, and diazepam on tone exposure-induced hyperexcitability of the inferior colliculus in the rat: possible therapeutic implications for pharmacological management of tinnitus and hyperacusis. Hear Res 97:46–53
Waldfahrer F (1999) Therapie von Tinnitus und akutem Hörverlust. HNO-Informationen 2
Wilhelm T, Agababov V, Lenarz T (2001) Rheologische Infusionstherapie, Neurotransmitterapplikation und Lidocain-Injektion bei Tinnnitus. HNO 49:93–101
Zenner HP (1998) Eine Systematik für Entstehungsmechanismen von Tinnitus. HNO 46:699–704
Zenner HP, Ernst A (1993) Cochlear-motor, transduction and signal-transfer tinnitus: models for three types of cochlear tinnitus. Eur Arch Otorhinolaryngol 249:447–454
Zuo J, Curtis LM, Yao X, ten Cate WJ, Bagger-Sjoback D, Hultcrantz M, Rarey KE (1995) Glucocorticoid receptor expression in the postnatal rat cochlea. Hear Res 87:220–227
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Medizin Verlag Heidelberg
About this chapter
Cite this chapter
Mazurek, B., Haupt, H., Gross, J. (2005). Medikamente für die Tinnitustherapie. In: Biesinger, E., Iro, H. (eds) Tinnitus. HNO Praxis heute, vol 25. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27491-X_4
Download citation
DOI: https://doi.org/10.1007/3-540-27491-X_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-22720-5
Online ISBN: 978-3-540-27491-9
eBook Packages: Medicine (German Language)